What would you do if the price of your everyday prescription rose 5,500%? That’s exactly what happened to Daraprim (pyrimethamine), a drug originally developed over 60 years ago, that helps immunocompromised HIV and cancer patients. After Martin Shkreli, a former hedge fund manager, acquired the drug for his company, Turing Pharmaceuticals, he raised the price by 55 times overnight. Shockingly, this type of gouging is fairly common.